Register | Login
World Pharma News .net


A new deal has been reached between the UK's Government and the pharmaceutical industry means that more patients will benefit from a wider range of innovative drug treatments at a fair price to the NHS. The flexible pricing scheme agreed will ensure that medicines fairly reflect their value to patients, branded drugs will see their price cut, and industry innovations will be encouraged and rewarded. As a result, patients will have faster access to new medicines that are clinically and cost effective.

Who Voted for this Story



Enter your email address:

Delivered by FeedBurner